Industry: Venture Capital
Annual Revenue Estimate: $10m+
Email Convention: NA
Overall Ranking (29%)
The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.
The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.
The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.
- 5 Stars
- 4 Stars
- 3 Stars
- 2 Stars
- 1 Star
To gain access to more statistics on this company and thousands of others including:1) % of interns receiving full time offers
2) The top undergraduate schools, majors and degrees this company targets
3) Interview stats breakdown on race, gender, military and sports data on the applicants,
Please click on the lock on the blue arrow and follow the instructions.
Want Access To These Statistics & Rankings?
- Free 1 month access by adding just 1 salary datapoint (here)
- REAL salary bonus data across 1,000+ companies
- Plus free 1 month access to 10,000+ interview insights
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity - and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
See in Google Maps
400 Hamilton Avenue, Palo Alto, CA, 94301, United States